<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220619055216N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-11-13</date_registration>
      <primary_sponsor>Yasouj University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of herbal medicineTrachyspermumammi L  on the symptoms of gastro-oesophageal reflux</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of the hydroalcoholic extract of the medicinal plant Xenian (Trachyspermumammi L.), omeprazole and their simultaneous use on the symptoms and quality of life related to the health of patients with gastro-oesophageal reflux.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64656</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Factorial, Purpose: Treatment, Randomization description: Block random assignment will be done in such a way that according to the number of groups under study (three groups) including intervention 1 (Zenian essential oil capsules 150 mg), intervention 2 (Omeprazole capsules 20 mg) and intervention 3 (Zenian essential oil capsules 150 mg and Omeprazole capsules 20 mg at the same time) and calculated based on the factorial law, i.e. 3 = 1 x 2 x 6 = !3, all the possible arrangements of the subjects considering A for the intervention group 1 (Zenian essential oil capsules 150 mg), B for the intervention group 2 (Omeprazole capsules 20 mg) and C for the intervention group 3 (Zenian essential oil capsules 150 mg and Omeprazole capsules 20 mg at the same time) will be compiled based on the following table:
   1      2      3      4       5      6
CBA CAB BCA BAC ACB ABC
Then, since the estimated sample size was 120 people, in each block, three samples, each representative of a study group and their arrangement order was also different, from these blocks, placement sampling will be done.</study_design>
      <phase>3</phase>
      <hc_freetext>Patients with gastroesophageal reflux.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Zenian essential oil capsules 150 mg: They use it once a day for 4 weeks. Zenian essential oil is produced in Kashan essential oil Barich pharmaceutical company. In order to determine the safe dose and prepare herbal soft gel capsules according to the available sources, the maximum dose of essential oils studied in medicinal plants in humans for daily oral consumption for Zenian is equal to 500 mg. To prepare the ethanolic extract, the plant sample (Zenian seeds) was dried in the shade (room temperature) after collection. After it was ensured that the seeds were completely dried, they were powdered by a mill, then to prepare the ethanolic extract, 100 grams of the dried powder was mixed with 500 cc of 70% ethanol and kept for 48 hours at room temperature and in the dark (22 °C) is kept. Then, the obtained extract was filtered by filter paper and 70% alcohol solution was added to it again for another 24 hours and kept in the same conditions as before. After this time, it was filtered again by filter paper and the solution was put into a rotary evaporator at a speed of 100 revolutions per minute to remove alcohol, and finally the said solution was dried at 40 degrees Celsius in an incubator. Intervention 2: Intervention group 2: Omeprazole capsules 20 mg: It will be used once a day for 4 weeks. Intervention 3: Intervention group 3: Zenian essential oil capsules 150 mg and Omeprazole capsules 20 mg at the same time: It will be used once a day for 4 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is NO more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ehsan Elahinia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Luqman St, Adl Square, Yasuj, Kohgiluyeh and Boyer-Ahmad, Islamic Republic of Iran</address>
        <city>Yasuj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7591111789</zip>
        <telephone>+98 74 3322 7573</telephone>
        <email>elahie@93gmail.com</email>
        <affiliation>Yasouj University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ehsan Elahinia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Luqman St, Adl Square, Yasuj, Kohgiluyeh and Boyer-Ahmad, Islamic Republic of Iran</address>
        <city>Yasuj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7591741417</zip>
        <telephone>+98 74 3322 7573</telephone>
        <email>elahie93@gmail.com</email>
        <affiliation>Yasouj University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being 18-60 years old
Consent to participate in the study and sign the informed consent form
Diagnosing gastroesophageal reflux by gastroenterologist based on ROME lll criteria
Body mass index (BMI) less than 30 (BMI&gt;30)
Absence of systemic diseases
Absence of neurological defects</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Taking antibiotics or non-steroidal anti-inflammatory drugs 2 weeks before the study
Previous participation in studies similar to the current research
Drug or alcohol abuse
Existence of gastrointestinal malignancy based on history, physical examination, laboratory tests (for example, the number of white blood cells, CRP, ESR, and upper endoscopy)
Liver and kidney function disorders based on laboratory tests
Pregnancy
History of severe allergy to medicinal plants
History of upper gastrointestinal surgery and serious diseases such as heart failure, diabetes, epilepsy, previous or current significant psychiatric disorders</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K21</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Gastro-esophageal reflux disease</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Zenian essential oil capsules 150 mg: They use it once a day for 4 weeks. Zenian essential oil is produced in Kashan essential oil Barich pharmaceutical company. In order to determine the safe dose and prepare herbal soft gel capsules according to the available sources, the maximum dose of essential oils studied in medicinal plants in humans for daily oral consumption for Zenian is equal to 500 mg. To prepare the ethanolic extract, the plant sample (Zenian seeds) was dried in the shade (room temperature) after collection. After it was ensured that the seeds were completely dried, they were powdered by a mill, then to prepare the ethanolic extract, 100 grams of the dried powder was mixed with 500 cc of 70% ethanol and kept for 48 hours at room temperature and in the dark (22 °C) is kept. Then, the obtained extract was filtered by filter paper and 70% alcohol solution was added to it again for another 24 hours and kept in the same conditions as before. After this time, it was filtered again by filter paper and the solution was put into a rotary evaporator at a speed of 100 revolutions per minute to remove alcohol, and finally the said solution was dried at 40 degrees Celsius in an incubator.</i_keyword>
      <i_keyword>Intervention group 2: Omeprazole capsules 20 mg: It will be used once a day for 4 weeks.</i_keyword>
      <i_keyword>Intervention group 3: Zenian essential oil capsules 150 mg and Omeprazole capsules 20 mg at the same time: It will be used once a day for 4 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Reflux Symptom Index. Timepoint: Before and after the intervention. Method of measurement: reflux symptom index questionnaire.</prim_outcome>
      <prim_outcome>Health-related quality of life - gastroesophageal reflux disease (GERD-HRQL. Timepoint: Before and after the intervention. Method of measurement: Health-related quality of life - gastroesophageal reflux disease (GERD-HRQL).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yasouj University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-03-20</approval_date>
        <contact_name>Ethics Committee of Yasouj University of Medical Sciences</contact_name>
        <contact_address>Yasuj University of Medical Sciences, Shahid Motahari Blvd., Yasuj, Kohgiluyeh and Boyer-Ahmad, Islamic Republic of Iran Yasuj Kohgilouyeh-va-Boyrahmad Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
